Senators urge U.S. anti-trust review of Pfizer-AstraZeneca plan
WASHINGTON May 14 (Reuters) - Six U.S. senators have asked the Federal Trade Commission and the Department of Justice to look at what they termed the anti-trust and anti-consumer implications of Pfizer's Inc potential takeover of UK's AstraZeneca PLC.
"Pfizer's record of reducing efforts to innovate and bring new products to market following prior acquisitions is plain," the senators, all Democrats, wrote to the agencies' top officials. (Reporting by Ros Krasny; Editing by Sandra Maler)
- Ukraine seeks to join NATO; defiant Putin compares Kiev to Nazis |
- California passes 'yes-means-yes' campus sexual assault bill
- In town halls, U.S. lawmakers hear voter anger over illegal migrants |
- IBM launches Watson system for research, hopes for breakthroughs
- U.N. says 43 Golan peacekeepers seized by Syria militants, 81 trapped